Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.

Brindley RL, Bauer MB, Hartley ND, Horning KJ, Currie KPM.

J Neurochem. 2017 Oct;143(2):171-182. doi: 10.1111/jnc.14149. Epub 2017 Sep 19.

2.

Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.

Bedse G, Hartley ND, Neale E, Gaulden AD, Patrick TA, Kingsley PJ, Uddin MJ, Plath N, Marnett LJ, Patel S.

Biol Psychiatry. 2017 Oct 1;82(7):488-499. doi: 10.1016/j.biopsych.2017.03.002. Epub 2017 Mar 15.

3.

Endocannabinoid signalling modulates susceptibility to traumatic stress exposure.

Bluett RJ, Báldi R, Haymer A, Gaulden AD, Hartley ND, Parrish WP, Baechle J, Marcus DJ, Mardam-Bey R, Shonesy BC, Uddin MJ, Marnett LJ, Mackie K, Colbran RJ, Winder DG, Patel S.

Nat Commun. 2017 Mar 28;8:14782. doi: 10.1038/ncomms14782.

4.

2-arachidonoylglycerol signaling impairs short-term fear extinction.

Hartley ND, Gunduz-Cinar O, Halladay L, Bukalo O, Holmes A, Patel S.

Transl Psychiatry. 2016 Mar 1;6:e749. doi: 10.1038/tp.2016.26.

5.

Prefrontal inputs to the amygdala instruct fear extinction memory formation.

Bukalo O, Pinard CR, Silverstein S, Brehm C, Hartley ND, Whittle N, Colacicco G, Busch E, Patel S, Singewald N, Holmes A.

Sci Adv. 2015 Jul;1(6). pii: e1500251. Epub 2015 Jul 31.

6.

Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation.

Bluett RJ, Gamble-George JC, Hermanson DJ, Hartley ND, Marnett LJ, Patel S.

Transl Psychiatry. 2014 Jul 8;4:e408. doi: 10.1038/tp.2014.53.

7.

Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses.

Ramikie TS, Nyilas R, Bluett RJ, Gamble-George JC, Hartley ND, Mackie K, Watanabe M, Katona I, Patel S.

Neuron. 2014 Mar 5;81(5):1111-1125. doi: 10.1016/j.neuron.2014.01.012.

8.

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation.

Hermanson DJ, Hartley ND, Gamble-George J, Brown N, Shonesy BC, Kingsley PJ, Colbran RJ, Reese J, Marnett LJ, Patel S.

Nat Neurosci. 2013 Sep;16(9):1291-8. doi: 10.1038/nn.3480. Epub 2013 Aug 4.

9.

Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.

Gamble-George JC, Conger JR, Hartley ND, Gupta P, Sumislawski JJ, Patel S.

Psychopharmacology (Berl). 2013 Aug;228(3):401-9. doi: 10.1007/s00213-013-3042-8. Epub 2013 Mar 13.

Supplemental Content

Loading ...
Support Center